Researchers identify a potential therapeutic target against cirrhosis and liver inflammation

by University of BarcelonaA new study by a team of the University of Barcelona could promote the design of drugs to treat these pathologies. Credit: University of BarcelonaThe RNF41 protein could

Updated on: January 29,2024

Researchers identify a potential therapeutic target against cirrhosis and liver inflammation

by University of BarcelonaA new study by a team of the University of Barcelona could promote the design of drugs to treat these pathologies. Credit: University of BarcelonaThe RNF41 protein could

Updated on:January 29,2024

New molecular subset of pediatric liver cancer identified

by Molly Chiu,Baylor College of MedicineGraphical abstract. Credit:Journal of Hepatology(2022). DOI: 10.1016/j.jhep.2022.04.035New research from Baylor College of Medicine and Texas

Updated on: May 27,2024

New molecular subset of pediatric liver cancer identified

by Molly Chiu,Baylor College of MedicineGraphical abstract. Credit:Journal of Hepatology(2022). DOI: 10.1016/j.jhep.2022.04.035New research from Baylor College of Medicine and Texas

Updated on:May 27,2024

How protein protects against fatty liver

by Deutsches Zentrum fuer Diabetesforschung DZDMicroscopic images of liver biopsies of three individuals with different degrees of liver fat accumulation. Credit: DIfENon-alcoholic fatty liver disease

Updated on: June 28,2024

How protein protects against fatty liver

by Deutsches Zentrum fuer Diabetesforschung DZDMicroscopic images of liver biopsies of three individuals with different degrees of liver fat accumulation. Credit: DIfENon-alcoholic fatty liver disease

Updated on:June 28,2024

Enhancing Anti-Tumor Immune Response in Small Cell Lung Cancer Through Combined Radiotherapy and CD47 Blockade: Mechanisms and Therapeutic Potential

Updated on: July 20,2024

Enhancing Anti-Tumor Immune Response in Small Cell Lung Cancer Through Combined Radiotherapy and CD47 Blockade: Mechanisms and Therapeutic Potential

Updated on:July 20,2024

Norovirus study shows how bile acids in breast milk affect newborn gut health

by Jiayu Liang,University of FloridaGraphical abstract. Credit:Cell Host & Microbe(2024). DOI: 10.1016/j.chom.2024.08.003A University of Florida researcher has compiled the first

Updated on: September 11,2024

Norovirus study shows how bile acids in breast milk affect newborn gut health

by Jiayu Liang,University of FloridaGraphical abstract. Credit:Cell Host & Microbe(2024). DOI: 10.1016/j.chom.2024.08.003A University of Florida researcher has compiled the first

Updated on:September 11,2024

Acute pancreatitis may progress to chronic with sustained heavy alcohol use

by Lori SolomonMany patients with recurrent acute pancreatitis (RAP) and acute pancreatitis (AP) have high lifetime cumulative drinking and heavy daily alcohol use, suggesting disease progression towa

Updated on: June 12,2024

Acute pancreatitis may progress to chronic with sustained heavy alcohol use

by Lori SolomonMany patients with recurrent acute pancreatitis (RAP) and acute pancreatitis (AP) have high lifetime cumulative drinking and heavy daily alcohol use, suggesting disease progression towa

Updated on:June 12,2024

What Is Fatty Liver Disease?

What Is Fatty Liver Disease?ByAnnie KayUpdated on April 20, 2024Medically reviewed byRobert Burakoff, MDFatty liver is also known as hepatic steatosis. It happens when fat buil

Updated on: July 01,2024

What Is Fatty Liver Disease?

What Is Fatty Liver Disease?ByAnnie KayUpdated on April 20, 2024Medically reviewed byRobert Burakoff, MDFatty liver is also known as hepatic steatosis. It happens when fat buil

Updated on:July 01,2024

Metabolic reprogramming and HIF-1α signaling in liver fibrosis and pathological angiogenesis

Updated on: September 21,2024

Metabolic reprogramming and HIF-1α signaling in liver fibrosis and pathological angiogenesis

Updated on:September 21,2024

Ultrasonography of hepatocellular carcinoma: From diagnosis to prognosis

by Xia & He Publishing Inc.Hepatocellular carcinoma (HCC) is a prominent contributor to cancer-related mortality worldwide. Early detection and diagnosis of liver cancer can significantly improve

Updated on: July 17,2024

Ultrasonography of hepatocellular carcinoma: From diagnosis to prognosis

by Xia & He Publishing Inc.Hepatocellular carcinoma (HCC) is a prominent contributor to cancer-related mortality worldwide. Early detection and diagnosis of liver cancer can significantly improve

Updated on:July 17,2024

Liver function tests can ID occult disorders in systemic sclerosis

by Elana GotkineLiver function test (LFT) screening can identify occult hepatitis, cholestasis, and cholestatic hepatitis in patients with systemic sclerosis (SSc), according to a study published onli

Updated on: June 06,2024

Liver function tests can ID occult disorders in systemic sclerosis

by Elana GotkineLiver function test (LFT) screening can identify occult hepatitis, cholestasis, and cholestatic hepatitis in patients with systemic sclerosis (SSc), according to a study published onli

Updated on:June 06,2024

Novel pathway could lead to potential treatment for metabolic liver disease

by Hayley Mignacca,University of Massachusetts Medical SchoolLyz-IFNγR2−/−mice are rescued from fatty liver progression to MASH. Credit:Nature Communications(2024). DOI: 10.103

Updated on: September 02,2024

Novel pathway could lead to potential treatment for metabolic liver disease

by Hayley Mignacca,University of Massachusetts Medical SchoolLyz-IFNγR2−/−mice are rescued from fatty liver progression to MASH. Credit:Nature Communications(2024). DOI: 10.103

Updated on:September 02,2024

Protein controlling magnesium identified as therapeutic target for non-alcoholic fatty liver disease

by New York UniversityThe study identified the CNNM4 protein as a key regulator of magnesium (Mg) in the liver and potential therapeutic target for non-alcoholic fatty liver disease (NASH). Credi

Updated on: June 28,2024

Protein controlling magnesium identified as therapeutic target for non-alcoholic fatty liver disease

by New York UniversityThe study identified the CNNM4 protein as a key regulator of magnesium (Mg) in the liver and potential therapeutic target for non-alcoholic fatty liver disease (NASH). Credi

Updated on:June 28,2024